Endo International plc Income Statement

Ask AI

Financial Statements

In millions of USD; shares in millions, except per-share amounts

	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021	FY2020 12 months to Dec 31, 2020	FY2019 12 months to Dec 31, 2019
TOTAL REVENUES, NET
COSTS AND EXPENSES:
Cost of revenues
Selling, general and administrative
Research and development
Acquired in-process research and development
Litigation-related and other contingencies, net
Asset impairment charges
Acquisition-related and integration items, net
Interest expense, net
Interest expense, net
Loss on extinguishment of debt
Reorganization items, net
Other income, net
LOSS FROM CONTINUING OPERATIONS BEFORE INCOME TAX
INCOME TAX EXPENSE
LOSS FROM CONTINUING OPERATIONS
DISCONTINUED OPERATIONS, NET OF TAX (NOTE 4)
NET LOSS
NET LOSS PER SHARE—BASIC:
Continuing operations (in dollars per share)
Discontinued operations (in dollars per share)
Basic (in dollars per share)
NET LOSS PER SHARE—DILUTED:
Continuing operations (in dollars per share)
Discontinued operations (in dollars per share)
Diluted (in dollars per share)
WEIGHTED AVERAGE SHARES:
Basic (in shares)
Diluted (in shares)

Comments